SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 205.63-0.7%1:57 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (16045)2/28/1998 7:15:00 PM
From: Cacaito  Read Replies (1) of 32384
 
Is Ligand glucocorticoid receptor program with (Glaxo?) in Phase I or Phase II ? This area of research could be the one to generate the $1 billion drug.

Imagine a potent antiinflamatory without all the side effects of the steroids.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext